Katherine M. Clark bought AbbVie Inc (NYSE: ABBV)
Katherine M. Clark (D-MA), a U.S. Representative, has disclosed 5 trades in AbbVie Inc (ABBV) since 2014, 2 purchases and 3 sales, worth an estimated $65K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Katherine M. Clark bought $1,001 - $15,000 of AbbVie Inc (NYSE: ABBV) on November 13, 2014. Since that trade, ABBV is up +558.44% against the S&P 500 up +333.77%, an outperformance of +224.67%.
Across these filings, Katherine M. Clark has been a net seller of ABBV (a buy-to-sell ratio of 0.67). The most recent disclosed ABBV transaction shown was dated December 16, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Katherine M. Clark's ABBV trades vs the price
ABBV is up +558.44% since Katherine M. Clark bought on November 13, 2014, versus +333.77% for the S&P 500.
Performance since this trade
All Katherine M. Clark ABBV trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Katherine M. Clark & ABBV trading FAQ
Is it legal for Katherine M. Clark to trade AbbVie Inc (ABBV) stock?
Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Katherine M. Clark buy ABBV?
Katherine M. Clark disclosed a purchase of $1,001 - $15,000 of AbbVie Inc (ABBV) on November 13, 2014, according to public STOCK Act filings.
How has ABBV performed since Katherine M. Clark's trade?
Since Katherine M. Clark bought ABBV on November 13, 2014, the stock is up +558.44%, versus +333.77% for the S&P 500 over the same period, an outperformance of +224.67%.
How many times has Katherine M. Clark traded ABBV?
Katherine M. Clark has disclosed 5 ABBV trades since 2014 (2 purchases and 3 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ABBV trades?
Quantellect tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.
Katherine M. Clark's ABBV tradesAll congressional filings for AbbVie IncKatherine M. Clark's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.